THIS SITE IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY

Prescribing information and adverse event reporting statement can be found in the footer

Adult ADHD Conference

Watch our ADHD study day on demand, where we were joined by Mr Kobus van Rensburg, Dr Joe Johnson, Dr Olimpia Belea, Dr Asif Bachlani and Dr Judith Mohring. They explored key challenges in adult ADHD care, including the impact of comorbidities, coping strategies that mask symptoms, and complexities in diagnosing women. The conference also covers dual diagnoses with autism, treatment optimisation, and the link between ADHD and addiction.

This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is intended for UK healthcare professionals.

Your certificate will be available in your account once you have watched the on-demand video.

Login to get full access to this resource

Agenda

Comorbidities and ADHD
Dr Joe Johnson, Consultant Psychiatrist and North West Lead for UKAAN (UK Adult ADHD Network), Mersey Care NHS Foundation Trust.
ADHD and Substance Misuse
Dr Olimpia Belea, MRCPsych, Consultant Psychiatrist, Sutton and Merton ADHD service, South West London & St George's Mental Health NHS Trust.
Treating ADHD (AuDHD) in Clinical Practice
Dr Asif Bachlani, FRCPsych, Consultant Psychiatrist and Clinical Lead for Woking Autism/AuDHD Pathway.
ADHD in Women Across the Lifespan
Dr Judith Mohring, Consultant Psychiatrist and Managing Director at The Natural Psychiatrist.
The Diagnostic Value of Self-Developed Strategies Prior to a Confirmed ADHD Diagnosis
Mr Kobus van Rensburg, Consultant Clinical Psychologist and President of the UK Adult ADHD Network (UKAAN).

Learning Objectives

  • To explore the prevalence and clinical impact of comorbidities experienced by adults with ADHD, and how these can influence the assessment, treatment and overall management of patients
  • To examine the diagnostic value of self-developed coping strategies in individuals prior to a confirmed ADHD diagnosis and how these behaviours may obscure or inform diagnostic assessments in adults
  • To discuss the management of ADHD and co-occurring ADHD and autism, highlighting medication choices and strategies for optimising treatment in everyday clinical practice
  • To uncover and analyse the challenges associated with diagnosing ADHD in women, with the goal of improving understanding of how hormonal variation across the lifespan influences symptom presentation and what this means for the treatment of ADHD in women
  • To understand the connection between ADHD and addiction, highlighting the key risk factors and challenges while exploring evidence-based approaches for treatment in clinical practice

Related Resources